Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Clinical Chemistry
|
December 17, 2009
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics
Henry Rodriguez, Zivana Tezak, Mehdi Mesri, et al.
The Oncologist
|
October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2015
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim, Gwynn Ison, Amy E McKee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2021
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions
Janice Kim, Diana Bradford, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review
Shaily Arora, Preeti Narayan, Christy L Osgood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Brian L Heiss, Elaine Chang, Xin Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Jianjin Xu, Chana Weinstock, et al.
BMC Genomics
|
September 30, 2004
Microarrays for global expression constructed with a low redundancy set of 27,500 sequenced cDNAs representing an array of developmental stages and physiological conditions of the soybean plant
Lila O Vodkin, Anupama Khanna, Robin Shealy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review
Shaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2020
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan, Sakar Wahby, Jennifer J Gao, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Clinical Chemistry
|
December 17, 2009
Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics
Henry Rodriguez, Zivana Tezak, Mehdi Mesri, et al.
The Oncologist
|
October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2015
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim, Gwynn Ison, Amy E McKee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2021
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With <i>RET</i> Gene Mutations or Fusions
Janice Kim, Diana Bradford, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review
Shaily Arora, Preeti Narayan, Christy L Osgood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Brian L Heiss, Elaine Chang, Xin Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Jianjin Xu, Chana Weinstock, et al.
BMC Genomics
|
September 30, 2004
Microarrays for global expression constructed with a low redundancy set of 27,500 sequenced cDNAs representing an array of developmental stages and physiological conditions of the soybean plant
Lila O Vodkin, Anupama Khanna, Robin Shealy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review
Shaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2020
FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1
Preeti Narayan, Sakar Wahby, Jennifer J Gao, et al.
Page
of 6